Form 4: Medtronic EVP Kiil Reports Tax-Related Share Withholding

Medtronic plc's EVP and President of Cardiovascular, Harry Skip Kiil, reported the withholding of 1,702 ordinary shares for tax purposes related to restricted stock unit vesting.

Summary

• Harry Skip Kiil, EVP & President Cardiovascular at Medtronic plc, reported a transaction involving ordinary shares.
• On December 5, 2025, 1,702 ordinary shares were disposed of at a price of $101.36 per share.
• This disposition represents shares withheld for taxes upon the vesting of previously reported restricted stock units.
• Following this transaction, Harry Skip Kiil beneficially owns 34,177 ordinary shares directly.
• The reported beneficial ownership includes 264 shares acquired through dividend reinvestment since the last report.

Sentiment

Score: 5

Explanation: The filing reports a routine administrative transaction (tax withholding on RSU vesting) and dividend reinvestment, which is neutral in terms of company performance or outlook.

Positives

• The reporting person acquired 264 shares through dividend reinvestment, indicating continued ownership and participation in company distributions.

Negatives

• A disposition of 1,702 ordinary shares occurred, reducing the direct beneficial ownership.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This routine insider transaction, specifically a tax-related share withholding, is common practice for executives receiving equity compensation in publicly traded companies within the medical technology industry and generally does not reflect a change in strategic direction or operational performance.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine executive compensation event and not a discretionary sale.
• Employees: No direct impact beyond the executive involved.

Key Dates

Keywords

Medtronic, MDT, Insider Transaction, Form 4, Share Withholding, Restricted Stock Units, Executive Compensation, Beneficial Ownership